Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara Savoldo

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with NeuroblastomaAndras Heczey, Chrystal U Louis, Barbara Savoldo, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
Blood|September 11, 2013
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myelomaMonica Casucci, Benedetta Nicolis di Robilant, Laura Falcone, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Nature Medicine|October 13, 2020
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysisAndras Heczey, Amy N Courtney, Antonino Montalbano, et al.
Nature Cancer|October 1, 2024
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanismsXin Zhou, Ying Wang, Zhangqi Dou, et al.
The Journal of Clinical Investigation|August 15, 2017
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytesCarlos A Ramos, Brandon Ballard, Huimin Zhang, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Medrxiv : the Preprint Server for Health Sciences|July 23, 2024
Infectious Complications Following CD30 Chimeric Antigen Receptor T-Cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Blood|July 13, 2006
Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs)Barbara Savoldo, John A Goss, Markus M Hammer, et al.
Open Forum Infectious Diseases|September 22, 2025
Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in AdultsFelicia Cao, Yueling Xiu, Michael Mohnasky, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 13, 2017
CAR T Cells Administered in Combination with Lymphodepletion and PD-1 Inhibition to Patients with NeuroblastomaAndras Heczey, Chrystal U Louis, Barbara Savoldo, et al.
Cancer Immunology Research|February 6, 2021
Modifications to the Framework Regions Eliminate Chimeric Antigen Receptor Tonic SignalingElisa Landoni, Giovanni Fucá, Jian Wang, et al.
Blood|September 11, 2013
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myelomaMonica Casucci, Benedetta Nicolis di Robilant, Laura Falcone, et al.
Blood|January 30, 2010
Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantationKenneth P Micklethwaite, Barbara Savoldo, Patrick J Hanley, et al.
Nature Medicine|October 13, 2020
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysisAndras Heczey, Amy N Courtney, Antonino Montalbano, et al.
Nature Cancer|October 1, 2024
CAR-redirected natural killer T cells demonstrate superior antitumor activity to CAR-T cells through multimodal CD1d-dependent mechanismsXin Zhou, Ying Wang, Zhangqi Dou, et al.
The Journal of Clinical Investigation|August 15, 2017
Clinical and immunological responses after CD30-specific chimeric antigen receptor-redirected lymphocytesCarlos A Ramos, Brandon Ballard, Huimin Zhang, et al.
Pageof 16